Cancer Research

Will Ibtrozi Become the New Standard for ROS1-Positive NSCLC?
Management & Regulatory Will Ibtrozi Become the New Standard for ROS1-Positive NSCLC?

Imagine facing the battle against a form of lung cancer so rare that it affects only about 2% of those diagnosed with non-small cell lung cancer (NSCLC). This is the reality for those with ROS1-positive NSCLC, a disease that could soon see transformative change with the approval of Nuvation Bio's

Genomic Study Advances Equity in Prostate Cancer Treatment
Research & Development Genomic Study Advances Equity in Prostate Cancer Treatment

Imagine facing a life-threatening illness only to find that your race determines the quality of treatment you receive. This scenario, unthinkable to many, is a stark reality for individuals battling metastatic prostate cancer. However, recent groundbreaking research offers new avenues to overcome

CT Colonography: Cost-Effective Solution for Cancer Screening
Research & Development CT Colonography: Cost-Effective Solution for Cancer Screening

In the rapidly evolving field of colorectal cancer screening, innovative methods are continually being assessed for their effectiveness and cost-efficiency. Today, we delve into the nuances of two such methods: CT colonography and stool DNA testing. To guide us through this complex landscape, we

Can AI-Driven Imaging Transform Cancer Surgery Outcomes?
Tech & Innovation Can AI-Driven Imaging Transform Cancer Surgery Outcomes?

The landscape of cancer surgery is witnessing a significant transformation with the integration of artificial intelligence in medical imaging. These advanced technologies hold the potential to revolutionize cancer surgery by enhancing precision and improving patient outcomes. Perimeter Medical

Can AI Revolutionize Breast Cancer Diagnosis and Treatment?
Tech & Innovation Can AI Revolutionize Breast Cancer Diagnosis and Treatment?

The Hong Kong University of Science and Technology has recently unveiled a groundbreaking artificial intelligence tool named the Mixture of Modality Experts (MOME), promising to significantly advance breast cancer diagnosis and management. Designed to match the precision of seasoned radiologists,

Kansas City Teens Raise $300K for Childhood Cancer Research
Research & Development Kansas City Teens Raise $300K for Childhood Cancer Research

In the heart of Kansas City, an awe-inspiring movement has taken root, driven by a family's personal experience with childhood cancer. When Kristin Myers-Trysla's youngest son, Clayton, was diagnosed with a rare stage-4 brain cancer at just one year old, the family faced an immense challenge. They

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later